E Huczko

973 total citations
20 papers, 806 citations indexed

About

E Huczko is a scholar working on Molecular Medicine, Pharmacology and Infectious Diseases. According to data from OpenAlex, E Huczko has authored 20 papers receiving a total of 806 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Medicine, 11 papers in Pharmacology and 8 papers in Infectious Diseases. Recurrent topics in E Huczko's work include Antibiotic Resistance in Bacteria (15 papers), Antibiotics Pharmacokinetics and Efficacy (11 papers) and Antimicrobial Resistance in Staphylococcus (5 papers). E Huczko is often cited by papers focused on Antibiotic Resistance in Bacteria (15 papers), Antibiotics Pharmacokinetics and Efficacy (11 papers) and Antimicrobial Resistance in Staphylococcus (5 papers). E Huczko collaborates with scholars based in United States. E Huczko's co-authors include J Fung-Tomc, D P Bonner, Beatrice Minassian, B Kolek, Elizabeth Gradelski, R E Kessler, Terry M. Stickle, Lourdes Valera, Lauren M. Aleksunes and Thomas J. Dougherty and has published in prestigious journals such as Journal of Clinical Microbiology, Antimicrobial Agents and Chemotherapy and Journal of Antimicrobial Chemotherapy.

In The Last Decade

E Huczko

20 papers receiving 749 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E Huczko United States 15 356 345 317 273 114 20 806
Beatrice Minassian United States 14 323 0.9× 284 0.8× 330 1.0× 203 0.7× 142 1.2× 18 783
Bonifacio Dewasse United States 14 367 1.0× 273 0.8× 235 0.7× 264 1.0× 130 1.1× 21 678
Pamela McGhee United States 14 222 0.6× 286 0.8× 454 1.4× 248 0.9× 199 1.7× 26 760
Kim Credito United States 16 318 0.9× 308 0.9× 410 1.3× 255 0.9× 140 1.2× 27 776
B Kolek United States 13 206 0.6× 307 0.9× 173 0.5× 294 1.1× 151 1.3× 16 637
C W Hanson United States 14 316 0.9× 257 0.7× 265 0.8× 205 0.8× 189 1.7× 20 708
Dianne B. Hoellman United States 16 323 0.9× 308 0.9× 216 0.7× 264 1.0× 72 0.6× 23 635
Junichi Mitsuyama Japan 20 612 1.7× 289 0.8× 639 2.0× 229 0.8× 170 1.5× 44 1.1k
Suzanne E. Glickman United States 8 403 1.1× 118 0.3× 656 2.1× 156 0.6× 242 2.1× 12 899
F. J. Boswell United Kingdom 14 372 1.0× 441 1.3× 257 0.8× 348 1.3× 103 0.9× 17 785

Countries citing papers authored by E Huczko

Since Specialization
Citations

This map shows the geographic impact of E Huczko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Huczko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Huczko more than expected).

Fields of papers citing papers by E Huczko

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E Huczko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Huczko. The network helps show where E Huczko may publish in the future.

Co-authorship network of co-authors of E Huczko

This figure shows the co-authorship network connecting the top 25 collaborators of E Huczko. A scholar is included among the top collaborators of E Huczko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E Huczko. E Huczko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Clark, Junius M., J Fung-Tomc, Beatrice Minassian, et al.. (2002). In Vitro and In Vivo Activities of a Novel Cephalosporin, BMS-247243, against Organisms other than Staphylococci. Antimicrobial Agents and Chemotherapy. 46(4). 1108–1111. 1 indexed citations
2.
Fung-Tomc, J, Elizabeth Gradelski, Lourdes Valera, E Huczko, & D P Bonner. (2002). Synergistic activity of the novel des-fluoro(6) quinolone, garenoxacin (BMS-284756), in combination with other antimicrobial agents against Pseudomonas aeruginosa and related species. International Journal of Antimicrobial Agents. 20(1). 57–60. 8 indexed citations
3.
Fung-Tomc, J, Junius M. Clark, Beatrice Minassian, et al.. (2002). In Vitro and In Vivo Activities of a Novel Cephalosporin, BMS-247243, against Methicillin-Resistant and -Susceptible Staphylococci. Antimicrobial Agents and Chemotherapy. 46(4). 971–976. 41 indexed citations
4.
Fung-Tomc, J, Elizabeth Gradelski, E Huczko, Beatrice Minassian, & D P Bonner. (2001). Activity of gatifloxacin against strains resistant to ofloxacin and ciprofloxacin and its ability to select for less susceptible bacterial variants. International Journal of Antimicrobial Agents. 18(1). 77–80. 15 indexed citations
5.
Huczko, E, et al.. (2000). Susceptibility of bacterial isolates to gatifloxacin and ciprofloxacin from clinical trials 1997–1998. International Journal of Antimicrobial Agents. 16(4). 401–405. 21 indexed citations
6.
Fung-Tomc, J, et al.. (2000). In vitro antibacterial spectrum of a new broad-spectrum 8-methoxy fluoroquinolone, gatifloxacin. Journal of Antimicrobial Chemotherapy. 45(4). 437–446. 106 indexed citations
7.
Fung-Tomc, J, Beatrice Minassian, B Kolek, et al.. (2000). Antibacterial Spectrum of a Novel Des-Fluoro(6) Quinolone, BMS-284756. Antimicrobial Agents and Chemotherapy. 44(12). 3351–3356. 142 indexed citations
8.
Fung-Tomc, J, Theodore C. White, Beatrice Minassian, E Huczko, & D P Bonner. (1999). In vitro antifungal activity of BMS-207147 and itraconazole against yeast strains that are non-susceptible to fluconazole. Diagnostic Microbiology and Infectious Disease. 35(2). 163–167. 36 indexed citations
9.
Fung-Tomc, J, E Huczko, Beatrice Minassian, & D P Bonner. (1998). In Vitro Activity of a New Oral Triazole, BMS-207147 (ER-30346). Antimicrobial Agents and Chemotherapy. 42(4). 993–993. 41 indexed citations
10.
Fung-Tomc, J, E Huczko, Beatrice Minassian, & D P Bonner. (1998). In Vitro Activity of a New Oral Triazole, BMS-207147 (ER-30346). Antimicrobial Agents and Chemotherapy. 42(2). 313–318. 159 indexed citations
11.
Fung-Tomc, J, Elizabeth Gradelski, E Huczko, et al.. (1996). Differences in the resistant variants of Enterobacter cloacae selected by extended-spectrum cephalosporins. Antimicrobial Agents and Chemotherapy. 40(5). 1289–1293. 54 indexed citations
12.
Kessler, R E, J Fung-Tomc, B Kolek, et al.. (1995). In vitro activity of BMS-181139, a new carbapenem with potent antipseudomonal activity. Antimicrobial Agents and Chemotherapy. 39(2). 380–385. 10 indexed citations
13.
Fung-Tomc, J, E Huczko, Terry M. Stickle, et al.. (1995). Antibacterial activities of cefprozil compared with those of 13 oral cephems and 3 macrolides. Antimicrobial Agents and Chemotherapy. 39(2). 533–538. 36 indexed citations
14.
Fung-Tomc, J, E Huczko, Jacques Banville, et al.. (1995). Structure-activity relationships of carbapenems that determine their dependence on porin protein D2 for activity against Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy. 39(2). 394–399. 16 indexed citations
15.
Fung-Tomc, J, Beatrice Minassian, E Huczko, et al.. (1995). In vitro antifungal and fungicidal spectra of a new pradimicin derivative, BMS-181184. Antimicrobial Agents and Chemotherapy. 39(2). 295–300. 40 indexed citations
16.
Gradelski, Elizabeth, J Fung-Tomc, E Huczko, & R E Kessler. (1993). Development of resistance in Pseudomonas aeruginosa to broad-spectrum cephalosporins via step-wise mutations. Journal of Antimicrobial Chemotherapy. 32(suppl B). 75–80. 23 indexed citations
17.
Fung-Tomc, J, E Huczko, Elizabeth Gradelski, et al.. (1991). Emergence of homogeneously methicillin-resistant Staphylococcus aureus. Journal of Clinical Microbiology. 29(12). 2880–2883. 10 indexed citations
18.
Fung-Tomc, J, et al.. (1991). In vitro activities of cefepime alone and with amikacin against aminoglycoside-resistant gram-negative bacteria. Antimicrobial Agents and Chemotherapy. 35(12). 2652–2654. 14 indexed citations
19.
Fung-Tomc, J, et al.. (1991). Inability of cephalothin testing to predict cefprozil susceptibility. Journal of Clinical Microbiology. 29(11). 2643–2647. 1 indexed citations
20.
Fung-Tomc, J, E Huczko, Mark S. Pearce, & R E Kessler. (1988). Frequency of in vitro resistance of Pseudomonas aeruginosa to cefepime, ceftazidime, and cefotaxime. Antimicrobial Agents and Chemotherapy. 32(9). 1443–1445. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Beatrice Minassian Breakdown of academic impact, for papers by Bonifacio Dewasse Breakdown of academic impact, for papers by Pamela McGhee Breakdown of academic impact, for papers by Kim Credito Breakdown of academic impact, for papers by B Kolek Breakdown of academic impact, for papers by C W Hanson Breakdown of academic impact, for papers by Dianne B. Hoellman Breakdown of academic impact, for papers by Junichi Mitsuyama Breakdown of academic impact, for papers by Suzanne E. Glickman Breakdown of academic impact, for papers by F. J. Boswell
Rankless by CCL
2026